BCSSX
Price
$43.68
Change
+$0.87 (+2.03%)
Updated
Apr 23 closing price
Net Assets
773.67M
VEXRX
Price
$92.56
Change
+$1.44 (+1.58%)
Updated
Apr 23 closing price
Net Assets
19.79B
Ad is loading...

BCSSX vs VEXRX

Header iconBCSSX vs VEXRX Comparison
Open Charts BCSSX vs VEXRXBanner chart's image
Brown Capital Mgmt Small Co Instl
Price$43.68
Change+$0.87 (+2.03%)
VolumeN/A
Net Assets773.67M
Vanguard Explorer Adm
Price$92.56
Change+$1.44 (+1.58%)
VolumeN/A
Net Assets19.79B
BCSSX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BCSSX vs. VEXRX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCSSX is a StrongBuy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. BCSSX (774M). VEXRX pays higher dividends than BCSSX: VEXRX (0.56) vs BCSSX (0.00). BCSSX was incepted earlier than VEXRX: BCSSX (13 years) vs VEXRX (23 years). BCSSX (1.11) is less costly to investors than VEXRX (0.34). VEXRX is a more actively managed with annual turnover of: 35.00 vs. BCSSX (12.00). VEXRX has a lower initial minimum investment than BCSSX: VEXRX (50000) vs BCSSX (500000). VEXRX annual gain was more profitable for investors over the last year : -12.82 vs. BCSSX (-36.37). VEXRX return over 5 years is better than : 15.80 vs. BCSSX (-53.12).
BCSSXVEXRXBCSSX / VEXRX
Total Expense Ratio1.110.34326%
Annual Report Gross Expense Ratio1.110.34326%
Fund Existence13 years23 years-
Gain YTD-19.171-14.722130%
Front LoadN/AN/A-
Min. Initial Investment500000500001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets774M19.8B4%
Annual Yield % from dividends0.000.56-
Returns for 1 year-36.37-12.82284%
Returns for 3 years-52.32-9.40556%
Returns for 5 years-53.1215.80-336%
Returns for 10 years-43.72-1.762,479%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF